nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—Salbutamol—chronic obstructive pulmonary disease	0.367	1	CrCtD
Clenbuterol—Pirbuterol—Salbutamol—chronic obstructive pulmonary disease	0.0897	0.447	CrCrCtD
Clenbuterol—TNF—chronic obstructive pulmonary disease	0.0652	0.296	CbGaD
Clenbuterol—Terbutaline—Salbutamol—chronic obstructive pulmonary disease	0.0596	0.297	CrCrCtD
Clenbuterol—ADRB2—chronic obstructive pulmonary disease	0.0578	0.262	CbGaD
Clenbuterol—Bupranolol—Salbutamol—chronic obstructive pulmonary disease	0.0515	0.256	CrCrCtD
Clenbuterol—CYP1A1—chronic obstructive pulmonary disease	0.0495	0.225	CbGaD
Clenbuterol—CYP1A2—chronic obstructive pulmonary disease	0.0478	0.217	CbGaD
Clenbuterol—ADRB2—Salbutamol—chronic obstructive pulmonary disease	0.0354	0.193	CbGbCtD
Clenbuterol—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.0348	0.19	CbGbCtD
Clenbuterol—ADRB2—Formoterol—chronic obstructive pulmonary disease	0.0268	0.146	CbGbCtD
Clenbuterol—ADRB2—Arformoterol—chronic obstructive pulmonary disease	0.0268	0.146	CbGbCtD
Clenbuterol—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.0264	0.144	CbGbCtD
Clenbuterol—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.0264	0.144	CbGbCtD
Clenbuterol—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.00694	0.0378	CbGbCtD
Clenbuterol—Bambuterol—ADRB2—chronic obstructive pulmonary disease	0.000462	0.301	CrCbGaD
Clenbuterol—Pirbuterol—ADRB2—chronic obstructive pulmonary disease	0.00035	0.228	CrCbGaD
Clenbuterol—Terbutaline—ADRB2—chronic obstructive pulmonary disease	0.000286	0.186	CrCbGaD
Clenbuterol—Bupranolol—ADRB2—chronic obstructive pulmonary disease	0.000226	0.147	CrCbGaD
Clenbuterol—Salbutamol—ADRB2—chronic obstructive pulmonary disease	0.000212	0.138	CrCbGaD
Clenbuterol—TNF—Transcriptional regulation of white adipocyte differentiation—TGFB1—chronic obstructive pulmonary disease	2.63e-05	0.00096	CbGpPWpGaD
Clenbuterol—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	2.62e-05	0.000954	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.61e-05	0.000954	CbGpPWpGaD
Clenbuterol—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	2.58e-05	0.000942	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	2.58e-05	0.000941	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	2.58e-05	0.00094	CbGpPWpGaD
Clenbuterol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	2.54e-05	0.000928	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	2.51e-05	0.000915	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	2.48e-05	0.000905	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	2.48e-05	0.000904	CbGpPWpGaD
Clenbuterol—TNF—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—chronic obstructive pulmonary disease	2.45e-05	0.000896	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—TP53—chronic obstructive pulmonary disease	2.45e-05	0.000894	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	2.44e-05	0.000889	CbGpPWpGaD
Clenbuterol—CYP1A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.43e-05	0.000887	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	2.41e-05	0.000878	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.41e-05	0.000878	CbGpPWpGaD
Clenbuterol—CYP1A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.4e-05	0.000875	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	2.38e-05	0.00087	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	2.38e-05	0.000867	CbGpPWpGaD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	2.34e-05	0.000855	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.32e-05	0.000847	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.3e-05	0.00084	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	2.27e-05	0.000828	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—IL6—chronic obstructive pulmonary disease	2.24e-05	0.000819	CbGpPWpGaD
Clenbuterol—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	2.21e-05	0.000806	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—chronic obstructive pulmonary disease	2.2e-05	0.000803	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	2.18e-05	0.000796	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	2.14e-05	0.00078	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	2.14e-05	0.00078	CbGpPWpGaD
Clenbuterol—TNF—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	2.12e-05	0.000774	CbGpPWpGaD
Clenbuterol—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	2.12e-05	0.000774	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—IL1B—chronic obstructive pulmonary disease	2.11e-05	0.00077	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.11e-05	0.000769	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2.06e-05	0.00075	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.04e-05	0.000743	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	2.04e-05	0.000743	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	2.04e-05	0.000743	CbGpPWpGaD
Clenbuterol—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	2.03e-05	0.000741	CbGpPWpGaD
Clenbuterol—CYP1A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.03e-05	0.00074	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—TP53—chronic obstructive pulmonary disease	2.02e-05	0.000737	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.01e-05	0.000735	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	2.01e-05	0.000732	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	2.01e-05	0.000732	CbGpPWpGaD
Clenbuterol—CYP1A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2e-05	0.00073	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2e-05	0.000728	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	1.95e-05	0.000712	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	1.93e-05	0.000705	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	1.93e-05	0.000702	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—IL6—chronic obstructive pulmonary disease	1.91e-05	0.000696	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	1.87e-05	0.000682	CbGpPWpGaD
Clenbuterol—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	1.87e-05	0.000681	CbGpPWpGaD
Clenbuterol—CYP1A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.86e-05	0.00068	CbGpPWpGaD
Clenbuterol—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	1.84e-05	0.000673	CbGpPWpGaD
Clenbuterol—CYP1A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.84e-05	0.000671	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	1.83e-05	0.000669	CbGpPWpGaD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	1.83e-05	0.000668	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—IL1B—chronic obstructive pulmonary disease	1.81e-05	0.000662	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	1.79e-05	0.000655	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	1.79e-05	0.000654	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	1.79e-05	0.000653	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	1.78e-05	0.00065	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.76e-05	0.000642	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	1.75e-05	0.00064	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	1.73e-05	0.000632	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—IL6—chronic obstructive pulmonary disease	1.72e-05	0.000628	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	1.71e-05	0.000623	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	1.67e-05	0.00061	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.64e-05	0.000597	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.63e-05	0.000596	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	1.63e-05	0.000595	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—IL6—chronic obstructive pulmonary disease	1.58e-05	0.000578	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	1.57e-05	0.000573	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.55e-05	0.000566	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.54e-05	0.000563	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	1.54e-05	0.000562	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	1.54e-05	0.00056	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	1.53e-05	0.000558	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.52e-05	0.000554	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	1.52e-05	0.000553	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.51e-05	0.000551	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.46e-05	0.000531	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—APIP—chronic obstructive pulmonary disease	1.42e-05	0.000519	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	1.41e-05	0.000514	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	1.41e-05	0.000514	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	1.39e-05	0.000507	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.39e-05	0.000506	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—EGFR—chronic obstructive pulmonary disease	1.38e-05	0.000504	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.38e-05	0.000502	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.37e-05	0.000498	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	1.36e-05	0.000498	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	1.36e-05	0.000498	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.35e-05	0.000492	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.35e-05	0.000492	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.34e-05	0.000488	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.32e-05	0.000482	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	1.31e-05	0.000478	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—IL6—chronic obstructive pulmonary disease	1.3e-05	0.000476	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.3e-05	0.000475	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	1.3e-05	0.000474	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	1.3e-05	0.000474	CbGpPWpGaD
Clenbuterol—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.29e-05	0.000472	CbGpPWpGaD
Clenbuterol—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.28e-05	0.000465	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.27e-05	0.000464	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.25e-05	0.000456	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.25e-05	0.000455	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.24e-05	0.000454	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.24e-05	0.000454	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—TP53—chronic obstructive pulmonary disease	1.24e-05	0.000452	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—IL6—chronic obstructive pulmonary disease	1.24e-05	0.000451	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.23e-05	0.000447	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.22e-05	0.000446	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.21e-05	0.000441	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—LEP—chronic obstructive pulmonary disease	1.2e-05	0.000438	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.2e-05	0.000436	CbGpPWpGaD
Clenbuterol—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.19e-05	0.000433	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.18e-05	0.000432	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.18e-05	0.000431	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.18e-05	0.000431	CbGpPWpGaD
Clenbuterol—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.17e-05	0.000428	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.17e-05	0.000427	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—TP53—chronic obstructive pulmonary disease	1.16e-05	0.000424	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.14e-05	0.000415	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.13e-05	0.000411	CbGpPWpGaD
Clenbuterol—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.13e-05	0.000411	CbGpPWpGaD
Clenbuterol—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.11e-05	0.000405	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.1e-05	0.0004	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.05e-05	0.000382	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.03e-05	0.000377	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.01e-05	0.00037	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	9.7e-06	0.000354	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	9.48e-06	0.000346	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.41e-06	0.000343	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	9.34e-06	0.000341	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	9.16e-06	0.000334	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	9.16e-06	0.000334	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.1e-06	0.000332	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	9.06e-06	0.000331	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	8.97e-06	0.000327	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	8.64e-06	0.000315	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.61e-06	0.000314	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.51e-06	0.000311	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.46e-06	0.000309	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.22e-06	0.0003	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	7.85e-06	0.000286	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.81e-06	0.000285	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	7.72e-06	0.000282	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	7.55e-06	0.000276	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	7.39e-06	0.00027	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	7.38e-06	0.000269	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.29e-06	0.000266	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	7.23e-06	0.000264	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	7.22e-06	0.000264	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MMP9—chronic obstructive pulmonary disease	7.22e-06	0.000263	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.03e-06	0.000257	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	7.01e-06	0.000256	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.98e-06	0.000255	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	6.86e-06	0.00025	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	6.75e-06	0.000246	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	6.61e-06	0.000241	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.59e-06	0.000241	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	6.48e-06	0.000237	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.46e-06	0.000236	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.38e-06	0.000233	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.34e-06	0.000231	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	6.13e-06	0.000224	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.1e-06	0.000223	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6e-06	0.000219	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	6e-06	0.000219	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	5.95e-06	0.000217	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.92e-06	0.000216	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	5.84e-06	0.000213	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—EGFR—chronic obstructive pulmonary disease	5.83e-06	0.000213	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.67e-06	0.000207	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.43e-06	0.000198	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.43e-06	0.000198	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.4e-06	0.000197	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.33e-06	0.000194	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.28e-06	0.000193	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.02e-06	0.000183	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	5e-06	0.000183	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.94e-06	0.00018	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.91e-06	0.000179	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.67e-06	0.00017	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.63e-06	0.000169	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.61e-06	0.000168	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.51e-06	0.000165	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—IL6—chronic obstructive pulmonary disease	4.48e-06	0.000164	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.47e-06	0.000163	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.45e-06	0.000162	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.32e-06	0.000158	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.25e-06	0.000155	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.17e-06	0.000152	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.16e-06	0.000152	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.14e-06	0.000151	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.09e-06	0.000149	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.08e-06	0.000149	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.05e-06	0.000148	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.79e-06	0.000138	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.77e-06	0.000138	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.76e-06	0.000137	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.71e-06	0.000135	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.68e-06	0.000134	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.62e-06	0.000132	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.59e-06	0.000131	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.54e-06	0.000129	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.47e-06	0.000127	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.42e-06	0.000125	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.41e-06	0.000124	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.37e-06	0.000123	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.29e-06	0.00012	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.19e-06	0.000116	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.19e-06	0.000116	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	3.15e-06	0.000115	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.06e-06	0.000112	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.94e-06	0.000107	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.88e-06	0.000105	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.81e-06	0.000103	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.77e-06	0.000101	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.76e-06	0.000101	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.71e-06	9.88e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.64e-06	9.64e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.59e-06	9.43e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.52e-06	9.21e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.47e-06	9.01e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.31e-06	8.44e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.24e-06	8.17e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.21e-06	8.07e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.19e-06	7.99e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.18e-06	7.96e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.13e-06	7.77e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.12e-06	7.73e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.08e-06	7.6e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	2.05e-06	7.49e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.03e-06	7.41e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.02e-06	7.39e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.98e-06	7.23e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.96e-06	7.17e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.93e-06	7.03e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.82e-06	6.63e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.78e-06	6.49e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.67e-06	6.09e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.64e-06	5.97e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.63e-06	5.96e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.6e-06	5.84e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.37e-06	5.01e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.34e-06	4.9e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.31e-06	4.78e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.26e-06	4.59e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.25e-06	4.57e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.23e-06	4.49e-05	CbGpPWpGaD
